← Back to Search

Wearable Device

Walkasins and PhySens-IMM System--Single Arm for Mild Cognitive Impairment

Q: Are there opportunities for enrollment into this clinical trial presently?

<p>As per clinicaltrials.gov, this medical trial is actively seeking out volunteers to take part in the experiment. The initial post date was February 16th 2023 and it has since been updated as recently as the same day.</p>

Q: What is the aggregate amount of people participating in this medical experiment?

<p>Indeed, clinicaltrials.gov displays that this medical trial commenced recruitment on February 16th 2023 and is still available to new participants. Currently, 1 location needs to enroll a total of 20 patients.</p>

N/A

Waitlist Available

Led By John P Condon, MSEE

Research Sponsored by RxFunction Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 times during 1 session <1.5 hours (screening + walkasins off condition then walkasins on condition)

Awards & highlights

Study Summary

This trial studies a device to help improve balance & gait speed of those with mild cognitive impairments.

Eligible Conditions

Mild Cognitive Impairment
Cognitive Decline
Gait Disorders

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 times during 1 session <1.5 hours (screening + walkasins off condition then walkasins on condition)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 times during 1 session <1.5 hours (screening + walkasins off condition then walkasins on condition)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 times during 1 session <1.5 hours (screening + walkasins off condition then walkasins on condition) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in 4-Meter Gait Speed (Section 2 of the Short Physical Performance Battery)

Secondary outcome measures

Falls Efficacy Scale

Short Physical Performance Battery (SPPB)

Timed Up and Go (TUG)

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Walkasins and PhySens-IMM System--Single ArmExperimental Treatment1 Intervention

Participants who meet the eligibility criteria will don a pair of Walkasins and the PhySens-IMM System. They will perform some brief balance exercises (i.e., sensory integration exercises) and then complete the outcome assessments with their Walkasins turned off and without the use of an assistive device. After a rest period of about five minutes, they will repeat the outcome assessments with their Walkasins turned on.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Walkasins

2018

N/A

~90

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

RxFunction Inc.Lead Sponsor

2 Previous Clinical Trials

100 Total Patients Enrolled

Innovative Design Labs, Inc.UNKNOWN

John P Condon, MSEEPrincipal InvestigatorInnovative Design Labs, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for enrollment into this clinical trial presently?

"As per clinicaltrials.gov, this medical trial is actively seeking out volunteers to take part in the experiment. The initial post date was February 16th 2023 and it has since been updated as recently as the same day."

Answered by AI

What is the aggregate amount of people participating in this medical experiment?

"Indeed, clinicaltrials.gov displays that this medical trial commenced recruitment on February 16th 2023 and is still available to new participants. Currently, 1 location needs to enroll a total of 20 patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments

2023. "Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05723822.